Pfizer announces release of four generic drugs

PEAPACK, N.J. Pfizer’s generic pharmaceutical subsidiary announced Thursday that it had introduced four drugs to its product line.

Greenstone said it had introduced amoxicillin tablets in the 875 mg strength, a generic version of GlaxoSmithKline’s Amoxil; cefadroxil capsules in the 500 mg strength, a generic version of Warner Chilcott’s Duricef; cefdinir capsules in the 300 mg strength, a generic version of Abbott Labs’ Omnicef; and cefprozil tablets in the 250 mg and 500 mg strengths, a generic version of Bristol-Myers Squibb’s Cefzil.

The company said that the introduction of the products marked the beginning of a “new and more aggressive” business strategy, where it had previously marketed only authorized generics of off-patent Pfizer products.